2. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by ma-ternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998;352:343-346.
3. Oh SY, Hong JS, Seol HJ, Hwang HS, Park HS, Kim K, Ko HS, Kwak DW, Kim MY, Park MH, Oh MJ, Park JS, Kim SJ. Korean Society of Ultrasound in Obstetrics and Gynecology Research Group. 2014 First-trimester ultrasound forum from the Korean Society of Ultrasound in Obstetrics and Gynecology. Obstet Gynecol Sci 2015;58:1-9.
4. Sonek J, Nicolaides K. Additional first-trimester ultrasound markers. Clin Lab Med 2010;30:573-592.
5. Kurjak A, Kupesic S, Matijevic R, Kos M, Marton U. First tri-mester malformation screening. Eur J Obstet Gynecol Reprod Biol 1999;85:93-96.
6. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 2001;358:1665-1667.
7. Kagan KO, Cicero S, Staboulidou I, Wright D, Nicolaides KH. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 2009;33:259-264.
8. Jung E, Won HS, Lee PR, Kim A. Ultrasonographic measure-ment of fetal nasal bone length in the second trimester in Ko-rean population. Prenat Diagn 2007;27:154-157.
10. Falcon O, Faiola S, Huggon I, Allan L, Nicolaides KH. Fetal tri-cuspid regurgitation at the 11+0 to 13+6-week scan: association with chromosomal defects and reproducibility of the method. Ultrasound Obstet Gynecol 2006;27:609-612.
13. Donnenfeld AE, Lockwood D, Lamb AN. Prenatal diagnosis from cystic hygroma fluid: the value of fluorescence in situ hybridization. Am J Obstet Gynecol 2001;185:1004-1008.
15. Chaoui R, Benoit B, Mitkowska-Wozniak H, Heling KS, Nicol-aides KH. Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11-13-week scan. Ultrasound Obstet Gynecol 2009;34:249-252.
16. Lee MY, Won HS, Jeong BD, Hyun MK, Lee HY, Shim JY, Lee PR, Kim A. Measurement of intracranial translucency using three-dimensional ultrasound and Volume IT. Prenat Diagn 2012;32:472-475.
18. Salomon LJ, Alfirevic Z, Berghella V, Bilardo C, Hernandez-Andrade E, Johnsen SL, Kalache K, Leung KY, Malinger G, Munoz H, Prefumo F, Toi A, Lee W. ISUOG Clinical Standards Committee. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol 2011;37:116-126.
19. Song HK, Ryu HM, Roh SH, Park SH, Kim MY, Kim ES, Han HW, Choi SK, Lee YH, Yoo SJ. Prenatal diagnosis and sono-graphic findings of down syndrome: review of 30 cases. Korean J Obstet Gynecol 1997;40:2826-2832.
20. Vintzileos AM, Egan JF. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Am J Obstet Gynecol 1995;172:837-844.
21. Yeo L, Vintzileos AM. The second trimester genetic sonogram. In: Callen PW, editor. Ultrasonography in obstetrics and gynecology. 5th ed. London: Elsevier Health Sciences; 2011. p. 70-111.
23. Cho RC, Chu P, Smith-Bindman R. Second trimester prenatal ultrasound for the detection of pregnancies at increased risk of trisomy 18 based on serum screening. Prenat Diagn 2009;29:129-139.
24. Song MJ. Fetal sonography for the detection of chromosomal abnormality. J Korean Soc Ultrasound Med 2011;30:75-82.
26. Momma K. Cardiovascular anomalies associated with chromo-some 22q11.2 deletion syndrome. Am J Cardiol 2010;105:1617-1624.
28. Driscoll DA. Prenatal diagnosis of the 22q11.2 deletion syn-drome. Genet Med 2001;3:14-18.